These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 35891930)

  • 1. NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes.
    Dutta D; Liu J; Xiong H
    Int J Physiol Pathophysiol Pharmacol; 2022; 14(3):138-160. PubMed ID: 35891930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies.
    Zhao N; Di B; Xu LL
    Cytokine Growth Factor Rev; 2021 Oct; 61():2-15. PubMed ID: 34183243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice.
    Zeng J; Xie X; Feng XL; Xu L; Han JB; Yu D; Zou QC; Liu Q; Li X; Ma G; Li MH; Yao YG
    EBioMedicine; 2022 Jan; 75():103803. PubMed ID: 34979342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention.
    Zhang J; Ma X; Liu F; Zhang D; Ling J; Zhu Z; Chen Y; Yang P; Yang Y; Liu X; Zhang J; Liu J; Yu P
    Front Immunol; 2023; 14():1203389. PubMed ID: 37868953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein.
    Yalcinkaya M; Liu W; Islam MN; Kotini AG; Gusarova GA; Fidler TP; Papapetrou EP; Bhattacharya J; Wang N; Tall AR
    Sci Rep; 2021 Dec; 11(1):24432. PubMed ID: 34952919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19.
    Yong YY; Zhang L; Hu YJ; Wu JM; Yan L; Pan YR; Tang Y; Yu L; Law BY; Yu CL; Zhou J; Li M; Qin DL; Zhou XG; Wu AG
    Clin Immunol; 2022 Nov; 244():109093. PubMed ID: 35944881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of NLRP3 Inflammasome in SARS-Cov-2-Induced Multiorgan Dysfunction in Patients with COVID-19: A Review of Molecular Mechanisms.
    Babazadeh Z
    Tanaffos; 2023 Jan; 22(1):40-52. PubMed ID: 37920322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer.
    Batiha GE; Al-Gareeb AI; Rotimi D; Adeyemi OS; Al-Kuraishy HM
    Sci Afr; 2022 Nov; 18():e01407. PubMed ID: 36310607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammasomes during SARS-CoV-2 infection and development of their corresponding inhibitors.
    Diarimalala RO; Wei Y; Hu D; Hu K
    Front Cell Infect Microbiol; 2023; 13():1218039. PubMed ID: 37360532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 induces "cytokine storm" hyperinflammatory responses in RA patients through pyroptosis.
    Zheng Q; Lin R; Chen Y; Lv Q; Zhang J; Zhai J; Xu W; Wang W
    Front Immunol; 2022; 13():1058884. PubMed ID: 36532040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the Nexus of NLRP3 Inflammasomes and COVID-19 Pathogenesis: Unraveling Molecular Triggers and Therapeutic Strategies.
    He Q; Hu D; Zheng F; Chen W; Hu K; Liu J; Yao C; Li H; Wei Y
    Viruses; 2024 Jan; 16(2):. PubMed ID: 38399989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.
    Suryavanshi SV; Zaiachuk M; Pryimak N; Kovalchuk I; Kovalchuk O
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescuing fertility during COVID-19 infection: exploring potential pharmacological and natural therapeutic approaches for comorbidity, by focusing on NLRP3 inflammasome mechanism.
    Hosseini E; Kohan-Ghadr HR; Bazrafkan M; Amorim CA; Askari M; Zakeri A; Mousavi SN; Kafaeinezhad R; Afradiasbagharani P; Esfandyari S; Nazari M
    J Assist Reprod Genet; 2023 May; 40(5):1173-1185. PubMed ID: 36892705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in the relationship between NLRP3 inflammasome and lung injury in COVID-19].
    Ren Z; Che P; Li Z; Mo M; Zhang S; Zhang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Sep; 37(9):844-850. PubMed ID: 34533131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation.
    Chang YS; Ko BH; Ju JC; Chang HH; Huang SH; Lin CW
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365944
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Shin SW; Cho IH
    J Ginseng Res; 2023 Jan; 47(1):23-32. PubMed ID: 36213093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of NLRP3 inflammasome in COVID-19 and periodontitis: Possible protective effect of melatonin.
    Şehirli AÖ; Aksoy U; Koca-Ünsal RB; Sayıner S
    Med Hypotheses; 2021 Jun; 151():110588. PubMed ID: 33848919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protective erythropoietin evolutionary landscape, NLRP3 inflammasome regulation, and multisystem inflammatory syndrome in children.
    Papadopoulos KI; Papadopoulou A; Aw TC
    Hum Cell; 2023 Jan; 36(1):26-40. PubMed ID: 36310304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe COVID-19: NLRP3 Inflammasome Dysregulated.
    van den Berg DF; Te Velde AA
    Front Immunol; 2020; 11():1580. PubMed ID: 32670297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-Related Overactivation of NLRP3 Inflammasome Increases Lethality of the Male COVID-19 Patients.
    Zhang H; Tang Y; Tao J
    Front Mol Biosci; 2021; 8():671363. PubMed ID: 34150848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.